Megaloblastic anaemia and pancytopenia secondary to prophylactic cotrimoxazole therapy.
Tapp
H
H
Haematology/Oncology Unit, Women's and Children's Hospital, North Adelaide, Australia.
Savarirayan
R
R
D000749:Anemia, Megaloblastic / Q000139:chemically induced*; D000892:Anti-Infective Agents, Urinary / Q000009:adverse effects*; D019072:Antibiotic Prophylaxis / Q000009:adverse effects*; D005494:Folic Acid Deficiency / Q000139:chemically induced*; D006801:Humans; D007223:Infant; D008297:Male; D010198:Pancytopenia / Q000139:chemically induced*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects*
D000892:Anti-Infective Agents, Urinary; D015662:Trimethoprim, Sulfamethoxazole Drug Combination